Panbela Therapeutics, Inc.·4

Sep 15, 5:59 PM ET

Horvath Susan 4

4 · Panbela Therapeutics, Inc. · Filed Sep 15, 2021

Insider Transaction Report

Form 4
Period: 2021-09-13
Horvath Susan
V.P. of Finance & CFO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-09-13+12,13512,135 total
    Exercise: $2.26Exp: 2031-09-13Common Stock (12,135 underlying)
Footnotes (1)
  • [F1]The stock option is schedule to vest in three equal annual installments on September 13, 2022, 2023 and 2024.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4